Ozbun, Michelle Adair
Professor, Departments of Molecular Genetics & Microbiology; Obstetrics and Gynecology, The University of New Mexico School of Medicine Co-Leader, Head and Neck Cancer Clinical Working Group, The University of New Mexico Comprehensive Cancer Center
Cancer Research Facility, The UNM Comprehensive Cancer Center
The University of New Mexico School of Medicine
Albuquerque, NM 87131, USA
Professor Ozbun is the Maralyn S. Budke Endowed Professor in Viral Oncology at the UNM Comprehensive Cancer Center of The University of New Mexico School of Medicine. She holds academic appointments in the Departments of Molecular Genetics & Microbiology (primary) and Obstetrics & Gynecology at The UNM School of Medicine. She is also the Co-leader of the Head and Neck Cancer Clinical Working Group at The UNM Comprehensive Cancer Center. She is the PI of the American Cancer Society’s Institutional Research Grant to UNM and the Program Director of the NIH NIAID NRSA-Funded “Infectious Disease and Inflammation Program” (IDIP) T32 Training Program.
Dr. Ozbun received a bachelor of science degree in Microbiology, with a minor in Chemistry, from Colorado State University in 1987 and a Ph.D. in Molecular Virology (with Janet S. Butel, Ph.D.) from Baylor College of Medicine, Houston, Texas, in 1994. She completed US-NIH-funded postdoctoral training with Dr. Craig Meyers at the Penn State University College of Medicine in Hershey, Pennsylvania from 1994-1998. Dr. Ozbun joined the faculty of the University of New Mexico School of Medicine in 1998.
Research in Dr. Ozbun’s lab spans from the basic science molecular virology of human papillomavirus infections and cancer progression to efforts aimed at HPV lesion treatments and improving clinical outcomes. In 16 years of continuous US-NIH funding as a PI, Dr. Ozbun and her research group have striven to improve our understanding of HPV infections and carcinogenesis by challenging the status quo and dogma in the HPV field using all available methods for virion production and replication, and insisting upon biologically relevant cell, tissue, and animal models for the study of infection and pathogenesis. In 2018 she was elected as the treasurer of the International Papillomavirus Society.
|Executive Committee – Board of Officers|